BioCentury
ARTICLE | Finance

IPO watch

GenMark Diagnostics IPO prices at bottom of range; breaks issue on first day

May 31, 2010 7:00 AM UTC

GenMark Diagnostics Inc. priced at the bottom of its range and broke issue, scarcely inspiring confidence in any incipient IPO window.

The diagnostics company had set an $8-$10 range and expected to sell 4.5 million shares. It dropped the range to $6-$8 on Friday and then priced at $6, selling 4.6 million shares...